A randomized trial of hydroxyurea versus VP16 in adult chronic myelomonocytic leukemia. Groupe Français des Myélodysplasies and European CMML Group. [electronic resource]
Producer: 19961107Description: 2480-7 p. digitalISSN:- 0006-4971
- Adult
- Aged
- Alopecia -- chemically induced
- Blood Cell Count -- drug effects
- Cross-Over Studies
- Etoposide -- adverse effects
- Female
- Humans
- Hydroxyurea -- adverse effects
- Karyotyping
- Leukemia, Myelomonocytic, Chronic -- drug therapy
- Life Tables
- Male
- Middle Aged
- Prognosis
- Risk Factors
- Splenomegaly -- drug therapy
- Survival Analysis
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.